OR WAIT null SECS
February 20, 2018
A new suite for the encapsulation of highly potent drugs will be added.
February 19, 2018
Colorcon's Opadry EZ provides superior slip and significantly reduces the probability of the tablet sticking to the throat or esophagus.
February 09, 2018
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
February 02, 2018
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
January 02, 2018
Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
December 06, 2017
Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step.
December 02, 2017
Softgel capsules are a popular dosage form among patients but they also provide a number of manufacturing benefits over liquid-filled hardgel capsules.
Modified-release lipid-based formulations in softgel capsules can address physiochemical and pharmacokinetic challenges posed by drug compounds.
Attracting and retaining qualified bio/pharma experts demands a mix of recognition, rewards, and opportunities.